Time domain ultra-wide band rf-enhanced chemotherapy for cancer treatment
AssigneeThe United States of America as represented by the Secretary of the Air Force
InventorForrest J. Agee
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe United States of America as represented by the Secretary of the Air Force
InventorForrest J. Agee
Estimating the term…
The ultra-wide band rf-enhanced chemotherapy for treatment of cancer and other intracellular diseases provides for increasing drug effectiveness. It also provides a means of treatment of inoperable cancers. The invention uses ultra-wide band short pulses to provide high electric field strength in diseased areas of a patient to induce electroporosis preferentially in the region to be treated by chemotherapy. The effect is to make the interiors of the cells in the affected region open to the chemotherapeutic agent. The treatment can be enhanced in its effectiveness thereby. It also enables treatment with reduced doses of the therapeutic agent and reduces side effects in other areas of the patient through the reduction of the total dosage. The invention makes specific use of the polarization of UWB fields and the very short duration of the pulsed electromagnetic fields induced into the region to be treated to minimize the absorbed rf energy associated with the treatment, making the heating of tissue negligible. The invention also makes it possible to select the size of the region being treated and in some embodiments to move the treated region electronically.
In an electroporosis treatment, an apparatus providing the required high electromagnetic field region at a desired location in a patient's body, said apparatus comprised of:
In an electroporosis treatment, an apparatus providing the required high electromagnetic field region at a desired location in a patient's body, said apparatus comprised of:
Dependencies are inferred from the claim text.